INSM Insmed Incorporated
Healthcare$108.87+2.48%ClosedMarket Cap: $23.60B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$213.11
Target (Median)
$213.50
Target Range
$160.00 - $269.00
Upside from current price: 95.7%
Rating Distribution
5 Strong Buy17 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Truist Securities | maintain | Buy | Buy |
| 2026-05-08 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-08 | Guggenheim | maintain | Buy | Buy |
| 2026-05-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-17 | Roth Capital | maintain | Buy | Buy |
| 2026-04-01 | Barclays | maintain | Overweight | Overweight |
| 2026-03-30 | Morgan Stanley | upgrade | Overweight | Equal Weight |
| 2026-03-26 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-25 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-24 | Stifel | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.49 | $2.80B | 15 |
| Sun Dec 31 | $3.59 | $3.87B | 17 |
| Mon Dec 31 | $7.44 | $5.05B | 13 |
| Tue Dec 31 | $10.43 | $6.31B | 7 |